Literature DB >> 15589120

NR0B1A: an alternatively spliced form of NR0B1.

John Ho1, Yao-Hua Zhang, Bing-Ling Huang, Edward R B McCabe.   

Abstract

The orphan nuclear receptor DAX1 (dosage-sensitive sex reversal-AHC critical region on the X chromosome gene 1), encoded by the NR0B1 gene, plays important roles in the development of the hypothalamic-pituitary-adrenal/gonadal (HPAG) axis as well as in sex determination. Mutations in NR0B1 cause the X-linked cytomegalic form of adrenal hypoplasia congenita (AHC), and associated hypogonadotropic hypogonadism (HH). Over-expression of NR0B1 results in sex reversal in mice and duplication of the 160kb DSS locus in human patients results in a sex-reversed phenotype (XY females). The purpose of these investigations was to determine if alternatively spliced forms of NR0B1 existed. Analysis of expressed sequence tag data predicted a truncated isoform of DAX1. We confirmed the presence of an alternatively spliced form of NR0B1, which we will refer to as NR0B1A, by reverse transcriptase-polymerase chain reaction (RT-PCR), and will refer to the deduced protein isoform as DAX1A. Sequencing of the NR0B1A cDNA revealed slight differences from the recently described splice form, DAX1alpha. NR0B1A is encoded by NR0B1 exon 1 and exon 2A located within the 3385 nt intron between NR0B1 exons 1 and 2. Exon 2A includes 35 nt of coding sequence. NR0B1A encodes a deduced protein sequence, DAX1A, of 400 amino acids compared with 470 amino acids for DAX1. RT-PCR detected expression of NR0B1A in adrenal gland, testis, ovary, and pancreas. The identification of NR0B1A and the deduced DAX1A requires reinterpretation of many previous experiments involving expression and knockout of NR0B1 and DAX1.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15589120     DOI: 10.1016/j.ymgme.2004.10.002

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  8 in total

1.  Evidence of adrenal failure in aging Dax1-deficient mice.

Authors:  Joshua O Scheys; Joanne H Heaton; Gary D Hammer
Journal:  Endocrinology       Date:  2011-07-05       Impact factor: 4.736

Review 2.  DAX1: Increasing complexity in the roles of this novel nuclear receptor.

Authors:  Edward R B McCabe
Journal:  Mol Cell Endocrinol       Date:  2007-01-08       Impact factor: 4.102

3.  DAX-1A (NR0B1A) expression levels are extremely low compared to DAX-1 (NR0B1) in human steroidogenic tissues.

Authors:  Y Nakamura; C Vargas Morris; H Sasano; W E Rainey
Journal:  Horm Metab Res       Date:  2008-09-25       Impact factor: 2.936

4.  Dax-1 and steroid receptor RNA activator (SRA) function as transcriptional coactivators for steroidogenic factor 1 in steroidogenesis.

Authors:  Bin Xu; Wei-Hsiung Yang; Isabelle Gerin; Chang-Deng Hu; Gary D Hammer; Ronald J Koenig
Journal:  Mol Cell Biol       Date:  2009-02-02       Impact factor: 4.272

5.  LXXLL motifs and AF-2 domain mediate SHP (NR0B2) homodimerization and DAX1 (NR0B1)-DAX1A heterodimerization.

Authors:  Anita K Iyer; Yao-Hua Zhang; Edward R B McCabe
Journal:  Mol Genet Metab       Date:  2007-08-07       Impact factor: 4.797

6.  Analysis of DAX1 (NR0B1) and steroidogenic factor-1 (NR5A1) in children and adults with primary adrenal failure: ten years' experience.

Authors:  Lin Lin; Wen-Xia Gu; Gokhan Ozisik; Wing S To; Catherine J Owen; J Larry Jameson; John C Achermann
Journal:  J Clin Endocrinol Metab       Date:  2006-05-09       Impact factor: 5.958

7.  Response to Lalli's comment: May the study of DAX-1 function just rely on its visualization?

Authors:  M Lanzino; S Andò
Journal:  Cell Death Dis       Date:  2014-01-02       Impact factor: 8.469

8.  X-Linked Adrenal Hypoplasia Congenita in a Boy due to a Novel Deletion of the Entire NR0B1 (DAX1) and MAGEB1-4 Genes.

Authors:  Aleksandra Rojek; Maciej R Krawczynski; Aleksander Jamsheer; Anna Sowinska-Seidler; Barbara Iwaniszewska; Ewa Malunowicz; Marek Niedziela
Journal:  Int J Endocrinol       Date:  2016-08-30       Impact factor: 3.257

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.